Brexpiprazole and Cipralex (escitalopram) (Cipralex 10 mg): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Medicines that affect the QT interval require a review of the combined cardiac risk.
Clinical significance and safety
Brexpiprazole and Cipralex (escitalopram): Medicines that affect the QT interval require a review of the combined cardiac risk. The relevant antipsychotic information calls for caution with QT-active partners; this is not a claim that it consistently causes clinically important QT prolongation on its own. Heart disease, a slow pulse and low potassium or magnesium can increase concern. A clinician determines whether ECG or electrolyte checks are needed. Fainting or new irregular palpitations require urgent assessment.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.